January 31, 2002
Global Alliance for TB Drug Development Obtains Exclusive Worldwide License of Anti-TB Drug, PA-824
January 31, 2002
More Chiron News
January 31, 2002
Chiron Licenses Compound to TB Drug Development Group
January 31, 2002
Chiron Corporation and Global Alliance for TB Drug Development Agree on License of PA-824 Compound for New Tuberculosis Therapeutics
January 19, 2002
Pharmaceutical Firms Battle Against Time to Make New TB Drug
January 14, 2002
Leading Indian Pharma Companies Keen to Participate in Development of Molecule for Drug-Resistant TB by 2010
January 13, 2002